Propanc Biopharma Launches Multi-Year Anti-Aging And Cancer Research Collaboration With Universities Of Jaén And Granada

Propanc Biopharma, Inc. (NASDAQ: PPCB) has entered into a multi-year Joint Research Collaboration Agreement with the Universities of Jaén and Granada in Spain, marking the fifth such agreement over seventeen years. The collaboration will focus on evaluating a senescence-modulating compound for anti-aging and supporting claims related to recently filed fibrosis and cancer patents. The project will be managed by Prof. Macarena Perán Quesada from UJA, with two postdoctoral fellows conducting the research, while Prof. Juan Antonio Marchal Corrales from UGR will oversee experimental designs.